Abstract
Introduction: Cardiovascular diseases (CVD) continue to be the major cause of morbidity and mortality worldwide, despite socioeconomic status [1]. Plant bioactive compounds are studied as complementary therapies in CVD. Among natural products, Nigella sativa and its bioactive compounds or derived products proved their efficacy against multiple cardiovascular risk factors through its antioxidant capacity, antihypertensive, hypolipidemic, or anti-atherosclerotic effects [2,3,4,5,6]. Therefore, this study aimed to evaluate the Nigella sativa oil (N. sativa oil) effect using an in vivo model of induced myocardial infarction with isoproterenol in rats. Materials and Methods: N. sativa oil was characterized for its bioactive compounds using Fourier-transform infrared spectroscopy (FTIR), Liquid chromatography-mass spectrometry (HPLC-MS), and gas chromatography-mass spectrometry (GC-MS) analysis. Thirty rats were divided into three groups as follows: the control group (saline solution), the isoproterenol group (45 mg/kg), and N. sativa oil group (isoproterenol—45 mg/kg and N. sativa oil 0.4 mL/100 g). Myocardial infarction was induced on the 14th day of the experiment. Electrocardiography was performed at the beginning and after one day from infarct induction. Serum analysis was evaluated using biochemical evaluation like alanine aminotransferase (ALT), aspartate aminotransferase (AST) and the myocardial fraction of creatine kinase (CK-Mb). The inflammatory status was evaluated by measuring tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) inflammatory cytokines. Results: N. sativa oil was rich in flavonoids, thymol derivatives α-thujene, p-cymene, α-pinene, and thymoquinone. Administration of N. sativa oil had a significant effect in reducing ventricular conduction while preventing isoproterenol cardiotoxic effects in the ventricular myocardium. Also, N. sativa oil administration significantly decreased the levels of pro-inflammatory cytokines when compared to the isoproterenol group. The levels of CK-Mb were as well significantly reduced. Conclusions: The anti-inflammatory and cardioprotective effects of N. sativa oil in the isoproterenol-induced experimental myocardial infarction indicate its potential use in human diets with promising applicability in the control of several associated CVD risk factors.
Author Contributions
Conceptualization, R.M.P. and A.D.B.; methodology, I.C.B.; software, V.S.C.; validation, I.C.B. and V.S.C.; formal analysis, I.C.B.; investigation, R.M.P.; resources, A.D.B.; data curation, R.M.P. and V.S.C.; writing—original draft preparation, R.M.P.; writing—review and editing, R.M.P. and V.S.C.; visualization, I.C.B.; supervision, A.D.B.; project administration, R.M.P.; funding acquisition, R.M.P. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The animal study protocol was approved by the Institutional Review Board (or Ethics Committee) of University of Medicine and Pharmacy Iuliu Hațieganu Cluj-Napoca (protocol code 126 from 26 June 2018).
Informed Consent Statement
Not applicable.
Data Availability Statement
The data presented in this study are available on request from the corresponding author.
Conflicts of Interest
The authors declare no conflict of interest.
References
- World Health Organization Cardiovascular Diseases. Available online: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1 (accessed on 11 May 2022).
- Pop, R.M.; Trifa, A.P.; Popolo, A.; Chedea, V.S.; Militaru, C.; Bocsan, I.C.; Buzoianu, A.D. Nigella sativa: Valuable perspective in the management of chronic diseases. Iran. J. Basic Med. Sci. 2020, 23, 699. [Google Scholar] [PubMed]
- Tiji, S.; Benayad, O.; Berrabah, M.; El Mounsi, I.; Mimouni, M. Phytochemical Profile and Antioxidant Activity of Nigella sativa L. Growing in Morocco. Sci. World J. 2021, 2021, 6623609. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Asgary, S.; Ghannadi, A.; Dashti, G.; Helalat, A.; Sahebkar, A.; Najafi, S. Nigella sativa L. improves lipid profile and prevents atherosclerosis: Evidence from an experimental study on hypercholesterolemic rabbits. J. Funct. Foods 2013, 5, 228–234. [Google Scholar] [CrossRef] [Scilit]
- Dehkordi, F.R.; Kamkhah, A.F. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam. Clin. Pharmacol. 2008, 22, 447–452. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Majdalawieh, A.F.; Yousef, S.M.; Abu-Yousef, I.A. Thymoquinone, a major constituent in Nigella sativa seeds, is a potential preventative and treatment option for atherosclerosis. Eur. J. Pharmacol. 2021, 909, 174420. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).